Autologous transplantation of genetically modified iris pigment epithelial cells: a promising concept for the treatment of age-related macular degeneration and other disorders of the eye.
about
Tissue engineering and cell based therapies, from the bench to the clinic: the potential to replace, repair and regenerateInhibition of glioma invasion by overexpression of pigment epithelium-derived factorGutless adenovirus: last-generation adenovirus for gene therapyAutologous translocation of the choroid and RPE in age-related macular degeneration: 1-year follow-up in 30 patients and recommendations for patient selection.Retinal transplantation: progress and problems in clinical application.Immunological factors in the pathogenesis and treatment of age-related macular degeneration.Antiangiogenic and Neurogenic Activities of Sleeping Beauty-Mediated PEDF-Transfected RPE Cells In Vitro and In VivoNeural Stem Cells Derived by Small Molecules Preserve Vision.Current treatment limitations in age-related macular degeneration and future approaches based on cell therapy and tissue engineering.Ocular epithelial transplantation: current uses and future potential.Replacement of the RPE monolayer.Identification of PLXDC1 and PLXDC2 as the transmembrane receptors for the multifunctional factor PEDF.Role of toll-like receptors in human iris pigment epithelial cells and their response to pathogen-associated molecular patterns.TrkB-T1 receptors on Muller cells play critical role in brain-derived neurotrophic factor-mediated photoreceptor protection against phototoxicity.High efficiency non-viral transfection of retinal and iris pigment epithelial cells with pigment epithelium-derived factor.Retinal Vascular Degeneration in the Transgenic P23H Rat Model of Retinitis Pigmentosa.Transplantation in the treatment of age-related macular degeneration: past, present and future directions
P2860
Q24799127-27280941-CC7E-4CAC-812D-B4D2A4944876Q28252870-0063131B-B385-4F38-9D1F-481C14968479Q28277560-AE5DFE39-9CA0-449E-8D8C-31F94F98AE29Q33291323-E2B29219-0386-41A8-9E88-945B07FE8CF6Q35186795-8C4EDAAA-B35A-421A-B2C4-6DAEFF299FE0Q36086191-1BF9038F-7BE2-4DF9-AD88-061E5406E7B1Q36369034-43BB11C8-0BCE-4CA7-B5F1-2F9402F6FFB5Q37149391-4CC11836-EDF1-45B4-B5B6-9496312D43B7Q37616149-C2455221-01EF-4B2C-976B-332FEC15FD0AQ37952317-88ECE625-5BE4-4A59-8346-E3A21E31BA9CQ40007627-618CB547-BD44-48D9-B379-20C164AA5365Q41655399-33EEB068-C7D7-440E-A9F2-7EAAC727A010Q41857141-93AB0E70-B4DF-48FF-A847-43A182AAC8D4Q43245702-B0B7ACC4-64F1-463B-B5B9-832F0B8010E9Q43278788-D556D2CE-A3D4-4557-AE64-994B6740E6C9Q55709318-02D8E1A1-3619-4AF9-9CCB-438E6B2C7EFBQ57838890-CC8E07D8-633C-400A-9DD7-5ED21C8DF8A7
P2860
Autologous transplantation of genetically modified iris pigment epithelial cells: a promising concept for the treatment of age-related macular degeneration and other disorders of the eye.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Autologous transplantation of ...... nd other disorders of the eye.
@ast
Autologous transplantation of ...... nd other disorders of the eye.
@en
type
label
Autologous transplantation of ...... nd other disorders of the eye.
@ast
Autologous transplantation of ...... nd other disorders of the eye.
@en
prefLabel
Autologous transplantation of ...... nd other disorders of the eye.
@ast
Autologous transplantation of ...... nd other disorders of the eye.
@en
P2093
P2860
P356
P1476
Autologous transplantation of ...... nd other disorders of the eye.
@en
P2093
Florian Kreppel
Gerhard Welsandt
Hanna Janicki
Irina Semkova
Jolanta Kozlowski
Stefan Kochanek
Thomas Luther
Ulrich Schraermeyer
P2860
P304
13090-13095
P356
10.1073/PNAS.202486199
P407
P577
2002-09-18T00:00:00Z